Haugesund Sanitetsforenings Revmatismesykehus AS
- Address
- lock Available on a paid plan
Musculoskeletal Diseases
Clinical research at Haugesund Sanitetsforenings Revmatismesykehus AS focuses on Musculoskeletal Diseases, with studies centered on painful joint conditions and inflammatory arthritis. The trials are designed to evaluate treatments that may improve symptom control, support function, and help guide better care for patients with chronic rheumatic disease.
- Osteoarthritis in the first carpometacarpal joint
- Rheumatoid arthritis
- Testing whether new treatment strategies improve pain relief and disease control
The site’s research includes both symptom-focused care for hand osteoarthritis and treatment management for rheumatoid arthritis, reflecting a practical interest in improving everyday outcomes for people with musculoskeletal conditions.
Hand Osteoarthritis Research
One trial at this Norwegian hospital explores painful inflammatory osteoarthritis of the thumb joint, comparing approaches intended to ease pain and improve hand-related function. The goal is to understand which option offers the most benefit for patients dealing with this common and often disabling condition.
- Painful inflammatory carpometacarpal osteoarthritis
- Comparing pain relief and functional improvement strategies
- Evaluating treatment effectiveness in routine clinical care
This research brings together medication-based care and supportive therapy to see how best to manage a difficult form of joint disease.
Rheumatoid Arthritis Treatment Monitoring
Another study at the Department of Rheumatology examines whether closer therapeutic drug monitoring can help maintain stable disease control in adults with rheumatoid arthritis. The trial is focused on reducing flares and improving long-term treatment effectiveness for people using biologic therapy.
- Rheumatoid arthritis management
- Maintaining sustained disease control
- Improving treatment guidance through drug monitoring
The research reflects a broader effort to personalize care in inflammatory arthritis and support more consistent outcomes over time.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Diakonhjemmet Sykehus AS1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Diakonhjemmet Sykehus AS2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 112 other sites in Norway
Therapeutic Area Benchmark — Norway
Select a therapeutic area to compare against other sites in Norway.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Norway
Market Share
Country: Norway
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Haugesund Sanitetsforenings Revmatismesykehus AS
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy of Intra-Articular Triamcinolone Acetonide, Sodium Chloride, and Occupational Therapy in Carpometacarpal Osteoarthritis | Diakonhjemmet Sykehus AS | Phase III | Recruiting | Nov 2023 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Adalimumab | 1 | Unknown | 2024-08-20 | 2024-08-20 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.